Comparison of the prognosis and lymph node metastasis between no tumor budding and low-grade tumor budding in T1 and T2 colorectal cancer

Abstract Tumor budding is a significant prognostic factor in colorectal cancer (CRC) management and is graded as follows: 0–4 buds as low, 5–9 buds as intermediate, and > 10 buds as high. However, the specific prognostic difference between cases with 0 buds (BD0) and those with 1–4 buds (BD1) is...

Full description

Saved in:
Bibliographic Details
Main Authors: Jong Yoon Lee, Mee Sook Roh, Jong Hoon Lee, Seun Ja Park, Hee Kyung Chang, Seok Won Jung, Ji Hye Kim, Busan Ulsan Gyeongnam Intestinal Study Group Society (BIGS)
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-84035-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850049253188042752
author Jong Yoon Lee
Mee Sook Roh
Jong Hoon Lee
Seun Ja Park
Hee Kyung Chang
Seok Won Jung
Ji Hye Kim
Busan Ulsan Gyeongnam Intestinal Study Group Society (BIGS)
author_facet Jong Yoon Lee
Mee Sook Roh
Jong Hoon Lee
Seun Ja Park
Hee Kyung Chang
Seok Won Jung
Ji Hye Kim
Busan Ulsan Gyeongnam Intestinal Study Group Society (BIGS)
author_sort Jong Yoon Lee
collection DOAJ
description Abstract Tumor budding is a significant prognostic factor in colorectal cancer (CRC) management and is graded as follows: 0–4 buds as low, 5–9 buds as intermediate, and > 10 buds as high. However, the specific prognostic difference between cases with 0 buds (BD0) and those with 1–4 buds (BD1) is not well established owing to a lack of comparative studies. This study aimed to examine and compare the rate of lymph node (LN) metastasis and prognosis by distinguishing between BD0 and BD1 within the low-grade category (0–4 buds) of tumor budding in submucosa (T1) and muscularis propria (T2) CRC. We retrospectively identified 223 cases of T1 and T2 CRC underwent surgery from 2015 to 2018 across three medical institutions using medical records. Pathology, including assessing tumor budding, was subsequently reconfirmed, and the recurrence and survival of patients were evaluated up to December 2023. Patients in the BD1 group exhibited a higher T stage than those in the BD0 group, accompanied by significantly increased rates of lymphovascular and perineural invasion. The prevalence of LN metastasis was 14.8%. No significant differences in LN metastasis were observed between the BD0 and BD1 groups. In a multivariate analysis exploring factors associated with LN metastasis, relevant factors included lymphatic invasion, perineural invasion, and ≥ 5 buds. There were no significant differences in 5-year survival and progression free survival rates between the BD0 and BD1 groups (P = 0.971). This study confirmed that there was no significant difference in LN metastasis or prognosis between patients with BD0 and BD1.
format Article
id doaj-art-510a3fe722074db0a11ea3f7bd33b4ce
institution DOAJ
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-510a3fe722074db0a11ea3f7bd33b4ce2025-08-20T02:53:44ZengNature PortfolioScientific Reports2045-23222025-01-011511910.1038/s41598-024-84035-6Comparison of the prognosis and lymph node metastasis between no tumor budding and low-grade tumor budding in T1 and T2 colorectal cancerJong Yoon Lee0Mee Sook Roh1Jong Hoon Lee2Seun Ja Park3Hee Kyung Chang4Seok Won Jung5Ji Hye Kim6Busan Ulsan Gyeongnam Intestinal Study Group Society (BIGS)Division of Gastroenterology, Department of Internal Medicine, Dong-A University College of MedicineDepartment of Pathology, Dong-A University College of MedicineDivision of Gastroenterology, Department of Internal Medicine, Dong-A University College of MedicineDepartment of Internal Medicine, Kosin University College of MedicineDepartment of Pathology, Kosin University College of MedicineDepartment of Internal Medicine, Ulsan University Hospital, University of Ulsan College of MedicineDepartment of Pathology, Ulsan University Hospital, University of Ulsan College of MedicineAbstract Tumor budding is a significant prognostic factor in colorectal cancer (CRC) management and is graded as follows: 0–4 buds as low, 5–9 buds as intermediate, and > 10 buds as high. However, the specific prognostic difference between cases with 0 buds (BD0) and those with 1–4 buds (BD1) is not well established owing to a lack of comparative studies. This study aimed to examine and compare the rate of lymph node (LN) metastasis and prognosis by distinguishing between BD0 and BD1 within the low-grade category (0–4 buds) of tumor budding in submucosa (T1) and muscularis propria (T2) CRC. We retrospectively identified 223 cases of T1 and T2 CRC underwent surgery from 2015 to 2018 across three medical institutions using medical records. Pathology, including assessing tumor budding, was subsequently reconfirmed, and the recurrence and survival of patients were evaluated up to December 2023. Patients in the BD1 group exhibited a higher T stage than those in the BD0 group, accompanied by significantly increased rates of lymphovascular and perineural invasion. The prevalence of LN metastasis was 14.8%. No significant differences in LN metastasis were observed between the BD0 and BD1 groups. In a multivariate analysis exploring factors associated with LN metastasis, relevant factors included lymphatic invasion, perineural invasion, and ≥ 5 buds. There were no significant differences in 5-year survival and progression free survival rates between the BD0 and BD1 groups (P = 0.971). This study confirmed that there was no significant difference in LN metastasis or prognosis between patients with BD0 and BD1.https://doi.org/10.1038/s41598-024-84035-6Colorectal neoplasmsTumor buddingLymph node metastasis
spellingShingle Jong Yoon Lee
Mee Sook Roh
Jong Hoon Lee
Seun Ja Park
Hee Kyung Chang
Seok Won Jung
Ji Hye Kim
Busan Ulsan Gyeongnam Intestinal Study Group Society (BIGS)
Comparison of the prognosis and lymph node metastasis between no tumor budding and low-grade tumor budding in T1 and T2 colorectal cancer
Scientific Reports
Colorectal neoplasms
Tumor budding
Lymph node metastasis
title Comparison of the prognosis and lymph node metastasis between no tumor budding and low-grade tumor budding in T1 and T2 colorectal cancer
title_full Comparison of the prognosis and lymph node metastasis between no tumor budding and low-grade tumor budding in T1 and T2 colorectal cancer
title_fullStr Comparison of the prognosis and lymph node metastasis between no tumor budding and low-grade tumor budding in T1 and T2 colorectal cancer
title_full_unstemmed Comparison of the prognosis and lymph node metastasis between no tumor budding and low-grade tumor budding in T1 and T2 colorectal cancer
title_short Comparison of the prognosis and lymph node metastasis between no tumor budding and low-grade tumor budding in T1 and T2 colorectal cancer
title_sort comparison of the prognosis and lymph node metastasis between no tumor budding and low grade tumor budding in t1 and t2 colorectal cancer
topic Colorectal neoplasms
Tumor budding
Lymph node metastasis
url https://doi.org/10.1038/s41598-024-84035-6
work_keys_str_mv AT jongyoonlee comparisonoftheprognosisandlymphnodemetastasisbetweennotumorbuddingandlowgradetumorbuddingint1andt2colorectalcancer
AT meesookroh comparisonoftheprognosisandlymphnodemetastasisbetweennotumorbuddingandlowgradetumorbuddingint1andt2colorectalcancer
AT jonghoonlee comparisonoftheprognosisandlymphnodemetastasisbetweennotumorbuddingandlowgradetumorbuddingint1andt2colorectalcancer
AT seunjapark comparisonoftheprognosisandlymphnodemetastasisbetweennotumorbuddingandlowgradetumorbuddingint1andt2colorectalcancer
AT heekyungchang comparisonoftheprognosisandlymphnodemetastasisbetweennotumorbuddingandlowgradetumorbuddingint1andt2colorectalcancer
AT seokwonjung comparisonoftheprognosisandlymphnodemetastasisbetweennotumorbuddingandlowgradetumorbuddingint1andt2colorectalcancer
AT jihyekim comparisonoftheprognosisandlymphnodemetastasisbetweennotumorbuddingandlowgradetumorbuddingint1andt2colorectalcancer
AT busanulsangyeongnamintestinalstudygroupsocietybigs comparisonoftheprognosisandlymphnodemetastasisbetweennotumorbuddingandlowgradetumorbuddingint1andt2colorectalcancer